(Q46784859)

25 December 2017

title

Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany (English)

1 reference

25 December 2017

polycystic kidney disease

0 references

1 reference

1 reference

24

1 reference

25 December 2017

author name string

Hartmut P H Neumann

1

1 reference

25 December 2017

Cordula Jilg

2

1 reference

25 December 2017

Janina Bacher

3

1 reference

25 December 2017

Zinaida Nabulsi

4

1 reference

25 December 2017

Angelica Malinoc

5

1 reference

25 December 2017

Barbara Hummel

6

1 reference

25 December 2017

Michael M Hoffmann

7

1 reference

25 December 2017

Nadina Ortiz-Bruechle

8

1 reference

25 December 2017

Sven Glasker

9

1 reference

25 December 2017

Przemyslaw Pisarski

10

1 reference

25 December 2017

Hannes Neeff

11

1 reference

25 December 2017

Annette Krämer-Guth

12

1 reference

25 December 2017

Markus Cybulla

13

1 reference

25 December 2017

Martin Hornberger

14

1 reference

25 December 2017

Jochen Wilpert

15

1 reference

25 December 2017

Ludwig Funk

16

1 reference

25 December 2017

Jörg Baumert

17

1 reference

25 December 2017

Dietrich Paatz

18

1 reference

25 December 2017

Dieter Baumann

19

1 reference

25 December 2017

Markus Lahl

20

1 reference

25 December 2017

Helmut Felten

21

1 reference

25 December 2017

Martin Hausberg

22

1 reference

25 December 2017

Klaus Zerres

23

1 reference

25 December 2017

Else-Kroener-Fresenius-ADPKD-Registry

25

1 reference

25 December 2017

language of work or name

English

0 references

publication date

8 January 2013

1 reference

25 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

25 December 2017

volume

28

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

1472-1487

1 reference

25 December 2017

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Everolimus in patients with autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Unified criteria for ultrasonographic diagnosis of ADPKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Predicting the effects of amino acid substitutions on protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Human non-synonymous SNPs: server and survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

MutationTaster evaluates disease-causing potential of sequence alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

von Hippel-Lindau disease: a clinical and scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS551

21 January 2018

Identifiers

DOI

10.1093/NDT/GFS551

1 reference

25 December 2017

PubMed ID

23300259

1 reference

25 December 2017